offers an in‑depth look at emerging anticancer agents, novel combinations and biomarker‑driven strategies that are transforming outcomes for patients with cancer. For academic researchers and clinicians ESMO TAT 2027 is the place to discuss...
in advancing cardiovascular health. Continuing its legacy of excellence, Heart Congress 2026 will serve as a vibrant platform for cross-disciplinary dialogue on the latest innovations in cardiovascular research, digital health, and preventive...
to invite you to this global gathering dedicated to advancing heart care and research. This conference serves as a platform for esteemed cardiologists, researchers, healthcare professionals, and industry leaders to convene and exchange...
Forum 2026 is a premier invite-only event uniting top pharma and healthcare supply chain leaders. This exclusive platform explores cutting-edge innovations in AI, IoT, blockchain, and cold chain logistics, while fostering valuable networking and...
and biotechnology. Scheduled to take place on October 12–13, 2026, in Singapore, the conference serves as a global platform to exchange knowledge, discuss emerging trends, and foster collaborations that accelerate drug discovery and therapeutic...
brings together scientists, researchers, industry leaders, regulators, and healthcare professionals to discuss transformative advancements in drug discovery, development, delivery systems, personalized medicine, and digital health. At NextGen...
AGILITY, the results demonstrated strong safety and effectiveness outcomes in patients with iliac artery disease, a common form of peripheral artery disease (PAD). The findings mark an important milestone in the efforts by BD to expand clinical...
working with SEVER Life Sciences / Nordic Pharma, and other factors that could influence the business and financial performance of SEVER Life Sciences / Nordic Pharma. SEVER Life Sciences / Nordic Pharma assumes no obligation to publicly update any...
thus far" said Thomas Rossi, PhD, Chairman of the Board of Arkayli Biopharma, Inc., "completing the preclinical research, formulation, and manufacturing preparation to support the IND filing. We look forward to entering the clinic with ARK001."...
Carterra®, a leading provider of high-throughput surface plasmon resonance (HT-SPR™) platforms for antibody and small molecule drug discovery, announced a research collaboration with AstraZeneca to develop hardware and software aimed at advancing...
MedaSystems, a SaaS platform for managing Expanded Access, Post-Trial Access and Investigator-Initiated Study programs, announced the release of MedaSystems Version 3.3, one of the company’s most significant platform updates to date. The release...
specialty drugs and other high-cost therapies is reshaping benefits budgets. Employers often judge pharmacy performance by discounts, rebates and guarantees, overlooking how utilization, new indications and larger eligible populations affect total...
manufacturers need component quality standards that reflect increasingly demanding expectations for consistency and performance. Premia™ Precision demonstrates our commitment to advancing quality for sensitive injectable applications by combining...
continuous or batch modes across a very broad throughput range (from 1 to 200 kg/h). Customers will be able to develop a formulation using small quantities of material, down to 1.5 kg, and then run from very small clinical batches to large...
expertise spanning preservation science, cell biology, cellular metabolism, bioengineering, immunology, stem cell biology, formulation, and manufacturing. The team will work to reduce dependence on cold-chain logistics by integrating specialized...
support for injectable drug programs, has launched the Ensera Alliance Network, bringing together leading device platform and fill-finish specialists to address the complexity of commercializing drug-device combination products. The network...
and the surf was big and intense. Going in, I was concerned about my resilience. I was completely fine. My vitality and performance over the past few months have genuinely surprised me. I take Niagen products every day because they are the best in...
improve patients' quality of life. By investing in talent, infrastructure, and biologics expansion, Bora continues to transform operations and achieve sustainable growth. Committed to making success "certain," Bora sets new standards in the...
therapy that provides antibacterial, antifungal, and anti-inflammatory activity in a convenient single-use formulation. The product contains 16.6 mg/mL florfenicol, 14.8 mg/mL terbinafine (equivalent to 16.6 mg/mL terbinafine hydrochloride), and...
in Milan, IT, evaluated outcomes among patients who switched from an injectable GLP-1 to the Wegovy® pill on Ro's platform. Ro is the leading provider of GLP-1s in the country. Since April 2025, Ro has worked with Novo and has been a key part of...
